Sun.Nov 28, 2021

Heart attacks struck Sek Kathiresan's family. He's devoted his life to stopping them.

Bio Pharma Dive

After several family members had early heart attacks, Kathiresan vowed to understand why they happen. His research journey has changed medical practice and led to a new biotech startup, Verve Therapeutics, that seeks to prevent them

No decrease in childhood cancer detection in Canada during the pandemic

Scienmag

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trial of Jazz’ cannabis drug in glioblastoma will start next year

Pharma Phorum

An investigator-led trial of Jazz Pharma’s cannabis extract-based drug Sativex in glioblastoma – an aggressive form of brain cancer – will get underway in the UK next year.

Researchers identify behavioral adaptations that may help Antarctic fishes adapt to warming Southern Ocean

Scienmag

At first glance, Antarctica seems inhospitable. Known for howling gales and extremely cold temperatures, the continent is blanketed with a mile-thick ice shelf. Occasional elephant seals and seabirds fleck the glacial shorelines.

Lessons in Supply Chain Digitization from PepsiCo and Conagra

Speaker: Craig Weiss, ConAgra Brands; Mari Roberts PepsiCo; and Matt Elenjickal, FourKites

Supply chain digitalization is key to success as market volatility, widespread disruption & stiff competition for consumer dollars puts pressure on every aspect of the supply chain. Register to hear how 2 global brands are accelerating digital transformation and increasing efficiency & automation throughout their operations.

Early-Stage Diabetes Treatment Wows Patients and Clinicians Alike

BioSpace

In October, Vertex Pharmaceuticals announced stunning results in a type 1 diabetes patient who had been dosed with the company’s experimental therapy

100
100

Sizing up the challenges in extracting lithium from geothermal brine

Scienmag

If you had a jar of marbles of many different colors but wanted only the green ones, how could you efficiently pick them out? What if it wasn’t marbles but a jar of glitter, and there was sand, glue, and mud mixed in? That begins to describe the complexity of the brine pumped out from […].

More Trending

Pharma pledges rapid response to Omicron COVID variant

Pharma Phorum

With governments around the world announcing measures to curb the new B.1.1.529 variant of COVID-19 – now christened Omicron – leading vaccine manufacturers have said they are poised to develop new shots if needed.

Promising Signals Emerge from Two Phase II Cancer Studies

BioSpace

Two biopharma companies developing therapeutics in the oncology space begin the week with strong signals in Phase II

QIAGEN and DiaSorin widen access to latent TB testing in the U.S. with FDA approval of QuantiFERON®-TB Gold Plus assay on LIAISON® XS

BioTech 365

QIAGEN and DiaSorin widen access to latent TB testing in the U.S. with FDA approval of QuantiFERON®-TB Gold Plus assay on LIAISON® XS QIAGEN and DiaSorin widen access to latent TB testing in the U.S. with FDA approval of QuantiFERON®-TB … Continue reading → Business Wire

Omicron Variant has Vaccine Makers Moving Fast and More COVID News

BioSpace

Omicron has caused the U.S. to install travel bans against several South African countries while vaccine makers rush to test their vaccines against it. For that news and more, continue reading

3 Ways End-to-End Visibility Helps Minimize the Risks of Ocean Freight

Download this playbook to learn how end-to-end visibility helps to mitigate risk associated with the ocean freight market.

Philips spotlights new and enhanced vendor-neutral radiology workflow solutions and scalable smart connected imaging systems at RSNA 2021

BioTech 365

Philips spotlights new and enhanced vendor-neutral radiology workflow solutions and scalable smart connected imaging systems at RSNA 2021 Philips spotlights new and enhanced vendor-neutral radiology workflow solutions and scalable smart connected imaging systems at RSNA 2021 November 28, 2021 Robust … Continue reading → GlobeNewswire

Gene-Based Therapy for Rare Skin Disease Succeeds in Phase III

BioSpace

Results from its GEM-3 trial on VYJUVEK demonstrated statistical significance in its ability to promote complete wound healing within six months compared to a placebo

New patent expiration for Alcon Pharms drug NAVSTEL

Drug Patent Watch

Annual Drug Patent Expirations for NAVSTEL Navstel is a drug marketed by Alcon Pharms Ltd and is included in one NDA. There is one patent protecting this drug. This drug…. The post New patent expiration for Alcon Pharms drug NAVSTEL appeared first on DrugPatentWatch - Make Better Decisions.

Sigilon Uncovers Possible Reason Behind Hemophilia A Trial Hold

BioSpace

Sigilon Therapeutics announced it may have discovered the reason why its experimental cell therapy treatment for severe hemophilia A was placed on clinical hold by the FDA

4 Silver Linings of the Chaotic Ocean Freight Market

Speaker: Peter Tirschwell, Chris Stauber, Sarah Barnes Humphrey, and Audrey Ross

Join this webinar exploring the silver linings that have emerged from the chaotic ocean freight market. The discussion will highlight solutions that prioritize digitization and build a more efficient international supply chain. Jan 25 at 10am CT.

Which pharmaceutical companies have the most drug patents in Canada?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Canada. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Canada?

Drugs 52

Clinical Catch-Up: November 22-26

BioSpace

Thanksgiving week was marked by numerous clinical trial announcements. Here’s a look

Boston Neighbors Net $256 Million for Treg and Allosteric Therapies

BioSpace

Quell Therapeutics scooped up $156 million in a Series B round this week. The company utilizes regulatory T cells to treat a variety of autoimmune and inflammatory diseases

66

Turnstone and Moffitt Cancer Center Team Up on TILs

BioSpace

New York-based Turnstone Biologics announced it is partnering with the Moffitt Cancer Center to develop tumor-infiltrating lymphocyte (TIL) therapies

The Smart Data Revolution: How AB InBev Drives Efficiency with Visibility Data

Speaker: AB InBev and FourKites

Register for our upcoming webinar to learn how leveraging the right data to make quick, well-informed decisions is the key to success in supply chain & logistics. Join FourKites and AB InBev to learn what’s possible with a data-driven supply chain strategy & real-time transportation visibility.

Career in Pharma as a Doctor: Everything You Need to Know

BioSpace

Are you a doctor looking for a job in the pharma industry? Here is everything you need to know about a career in pharma

Blueprint Adds Lengo's Precision Therapy to Lung Cancer Portfolio

BioSpace

The deal adds LNG-451, a highly selective brain-penetrant precision therapy targeting EGFR exon 20 insertion mutations, to its pipeline

61

Terns is Flirting with Milestones in Challenging NASH Space

BioSpace

Treatment for non-alcoholic steatohepatitis (NASH), a severe form of fatty liver disease, consists mainly of lifestyle modification – specifically dieting and weight loss

58

Merck's Molnupiravir Sheds Efficacy Points Ahead of Key FDA Meeting

BioSpace

?The latest data from Merck and Ridgeback Biotherapeutics' MOVe-OUT trial on the use of molnupiravir to treat COVID-19 in adults has shown a lower efficacy than previously reported

Modernizing Pharmaceutical Supply Chains

Speaker: Nimesh Patel, Gregory Demitrack, and Sarah Barnes Humphrey

Register for our upcoming webinar to better understand the state of the pharmaceutical supply chain. FourKites partnered with Accenture to survey supply chain executives working in pharmaceuticals, biotech, cell and gene therapy, medtech, and other related industries.

FDA Action Alert: Legend & Janssen, Merck & Ridgeback, Amryt, BeyondSpring and More

BioSpace

The U.S. Food and Drug Administration has a very busy calendar for the end of November and beginning of December. Here’s a look

Drugs 55